COVID-19 Increases Fatality of Fungal Infections, CDC Study Shows

Mortality rates for COVID-associated fungal infections were significantly higher compared to non-COVID-associated fungal infections, with rates reaching 49% versus 12%, respectively. Aspergillosis, invasive candidiasis, mucormycosis, and unspecified mycoses had the highest mortality rates. Hospitalizations for COVID-associated fungal infections involved longer stays, were more likely to involve intensive care, and were more likely to use invasive mechanical ventilation. COVID-19 infection is a substantial risk factor for certain fungal infections, particularly those caused by invasive molds, likely because of COVID-19-related immune system dysregulation and immunosuppressive therapies.